Literature DB >> 2693165

The plasma C-peptide and insulin responses to stimulation with intravenous glucagon and a mixed meal in well-controlled type 2 (non-insulin-dependent) diabetes mellitus: dependency on acutely established hyperglycaemia.

H J Gjessing1, B Reinholdt, O Pedersen.   

Abstract

The dose-response relationships between acutely established hyperglycaemia and the plasma C-peptide and insulin responses to i.v. stimulation with 1 mg of glucagon and a standard mixed meal were investigated in 10 patients with well-controlled Type 2 (non-insulin dependent) diabetes mellitus. Hyperglycaemia was maintained for 90 min before stimulation using a hyperglycaemic clamp technique. Each test was performed on different steady state blood glucose levels of approximately 6 mmol/l, approximately 12 mmol/l, and approximately 20 mmol/l, respectively. The plasma C-peptide and insulin responses after glucagon and the meal were potentiated markedly at each level of prestimulatory hyperglycaemia. After glucagon injection, the relative glucose potentiation of the insulin response was significantly higher than the relative glucose potentiation of the C-peptide response at each level of hyperglycaemia (p less than 0.01). This difference may be explained by a higher fractional hepatic removal of insulin at normoglycaemia, since the molar ratio between the incremental C-peptide and insulin responses after glucagon stimulation was higher at prestimulatory normoglycaemia (4.85 (3.65-12.05] than at the prestimulatory blood glucose concentrations approximately 12 mmol/l (2.41 (2.05-4.09] (p less than 0.01) and approximately 20 mmol/l (2.24 (1.37-3.62] (p less than 0.01). In conclusion, the islet B-cell responses to glucagon and a standard mixed meal are potentiated to a high degree by acutely established prestimulatory hyperglycaemia in patients with well-controlled Type 2 diabetes. Acute prestimulatory hyperglycaemia is also associated with a markedly reduced incremental C-peptide/insulin ratio after glucagon stimulation in such patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2693165     DOI: 10.1007/bf00297450

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  27 in total

1.  Insulin requirement in non-insulin-dependent diabetes mellitus: relation to simple tests of islet B-cell function and insulin sensitivity.

Authors:  H J Gjessing; L E Matzen; P C Pedersen; O K Faber; A Frøland
Journal:  Diabet Med       Date:  1988 May-Jun       Impact factor: 4.359

2.  Radioimmunological determination of human C-peptide in serum.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1975-12       Impact factor: 10.122

3.  Europium as a label in time-resolved immunofluorometric assays.

Authors:  I Hemmilä; S Dakubu; V M Mukkala; H Siitari; T Lövgren
Journal:  Anal Biochem       Date:  1984-03       Impact factor: 3.365

4.  Plasma and urinary C-peptide in the classification of adult diabetics.

Authors:  P Koskinen; J Viikari; K Irjala; H L Kaihola; P Seppälä
Journal:  Scand J Clin Lab Invest       Date:  1986-11       Impact factor: 1.713

5.  Therapeutic effect of tolbutamide in non-insulin dependent diabetes mellitus (NIDDM). Relation to beta-cell function.

Authors:  E M Damsgaard; O Faber; A Frøland; S Iversen
Journal:  Acta Endocrinol (Copenh)       Date:  1982-07

6.  Quantitative study of insulin secretion and clearance in normal and obese subjects.

Authors:  K S Polonsky; B D Given; L Hirsch; E T Shapiro; H Tillil; C Beebe; J A Galloway; B H Frank; T Karrison; E Van Cauter
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

7.  Relationship of islet function to insulin action in human obesity.

Authors:  J C Beard; W K Ward; J B Halter; B J Wallum; D Porte
Journal:  J Clin Endocrinol Metab       Date:  1987-07       Impact factor: 5.958

8.  The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.

Authors:  W T Garvey; J M Olefsky; J Griffin; R F Hamman; O G Kolterman
Journal:  Diabetes       Date:  1985-03       Impact factor: 9.461

9.  Effect of physical exercise on sensitivity and responsiveness to insulin in humans.

Authors:  K J Mikines; B Sonne; P A Farrell; B Tronier; H Galbo
Journal:  Am J Physiol       Date:  1988-03

10.  A comparison of serum C-peptide response to intravenous glucagon, and urine C-peptide, as indexes of insulin dependence.

Authors:  A Matsuda; I Kamata; Y Iwamoto; Y Sakamoto; T Kuzuya
Journal:  Diabetes Res Clin Pract       Date:  1985-10       Impact factor: 5.602

View more
  4 in total

1.  A simple clinical approach to discriminate between "true" and "pseudo" secondary failure to oral hypoglycaemic agents.

Authors:  L Scionti; P Misericordia; A Santucci; F Santeusanio; P Brunetti
Journal:  Acta Diabetol       Date:  1992       Impact factor: 4.280

2.  The effect of various blood glucose levels on post-glucagon C-peptide secretion in type 2 (non insulin-dependent) diabetes.

Authors:  I Nosari; G Lepore; M L Maglio; F Cortinovis; G Pagani
Journal:  J Endocrinol Invest       Date:  1992-02       Impact factor: 4.256

3.  Islet cell antibodies are associated with beta-cell failure also in obese adult onset diabetic patients.

Authors:  A Gottsäter; M Landin-Olsson; A Lernmark; P Fernlund; G Sundkvist
Journal:  Acta Diabetol       Date:  1994-12       Impact factor: 4.280

Review 4.  The clinical utility of C-peptide measurement in the care of patients with diabetes.

Authors:  A G Jones; A T Hattersley
Journal:  Diabet Med       Date:  2013-07       Impact factor: 4.359

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.